Antiviral drugs

In this chapter, we have reviewed side effects reported with the use of antivirals for the treatment of the following infections: coronavirus disease 2019 (COVID-19), cytomegalovirus (CMV), hepatitis B virus (HBV), hepatitis C Virus (HCV), herpes simplex viruses 1 and 2 (HSV-1, -2), human immunodefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuel, Essie, McNaught, Krysten A., Mulbah, Jessica L., HajiAlilou, Hazhir, Mody, Vicky, Cates, Drew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597564/
http://dx.doi.org/10.1016/bs.seda.2022.09.006
_version_ 1784816121521635328
author Samuel, Essie
McNaught, Krysten A.
Mulbah, Jessica L.
HajiAlilou, Hazhir
Mody, Vicky
Cates, Drew W.
author_facet Samuel, Essie
McNaught, Krysten A.
Mulbah, Jessica L.
HajiAlilou, Hazhir
Mody, Vicky
Cates, Drew W.
author_sort Samuel, Essie
collection PubMed
description In this chapter, we have reviewed side effects reported with the use of antivirals for the treatment of the following infections: coronavirus disease 2019 (COVID-19), cytomegalovirus (CMV), hepatitis B virus (HBV), hepatitis C Virus (HCV), herpes simplex viruses 1 and 2 (HSV-1, -2), human immunodeficiency virus (HIV), and influenza virus. The search engines PUBMED, EMBASE and International Pharmaceutical Abstracts (IPA) were utilized to identify literature published between January 1, 2021 to December 31, 2021.
format Online
Article
Text
id pubmed-9597564
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-95975642022-10-26 Antiviral drugs Samuel, Essie McNaught, Krysten A. Mulbah, Jessica L. HajiAlilou, Hazhir Mody, Vicky Cates, Drew W. Side Effects of Drugs Annual Article In this chapter, we have reviewed side effects reported with the use of antivirals for the treatment of the following infections: coronavirus disease 2019 (COVID-19), cytomegalovirus (CMV), hepatitis B virus (HBV), hepatitis C Virus (HCV), herpes simplex viruses 1 and 2 (HSV-1, -2), human immunodeficiency virus (HIV), and influenza virus. The search engines PUBMED, EMBASE and International Pharmaceutical Abstracts (IPA) were utilized to identify literature published between January 1, 2021 to December 31, 2021. Elsevier B.V. 2022 2022-10-26 /pmc/articles/PMC9597564/ http://dx.doi.org/10.1016/bs.seda.2022.09.006 Text en Copyright © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Samuel, Essie
McNaught, Krysten A.
Mulbah, Jessica L.
HajiAlilou, Hazhir
Mody, Vicky
Cates, Drew W.
Antiviral drugs
title Antiviral drugs
title_full Antiviral drugs
title_fullStr Antiviral drugs
title_full_unstemmed Antiviral drugs
title_short Antiviral drugs
title_sort antiviral drugs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597564/
http://dx.doi.org/10.1016/bs.seda.2022.09.006
work_keys_str_mv AT samuelessie antiviraldrugs
AT mcnaughtkrystena antiviraldrugs
AT mulbahjessical antiviraldrugs
AT hajialilouhazhir antiviraldrugs
AT modyvicky antiviraldrugs
AT catesdreww antiviraldrugs

Ejemplares similares